Myeloid Therapeutics
Immunology company focused on combining biology insights with cutting-edge technologies to harness myeloid cells and eradicate cancer and other diseases.
$50M ·
Source: BioSpace
Latest round on record: Series B+, May 2026, amount undisclosed.
All 2 rounds ↓Signals
Myeloid Therapeutics | 671 days from website to first raise on record
Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series B+ | undisclosed | — | fundraisingfox.com | |
| Round | $50M | — | BioSpace |
Timeline
- X account created
- Website created
Companies like Myeloid Therapeutics
EEurekaBio$40M Series B+ · Mar 2024QQubit PharmaceuticalsSeed · Jun 2022
CC. Light Technologi
BBeech BiotechSeed · Apr 2026
GGlycoXPre Seed · Jun 2026
LLegends$6M Seed · Mar 2024
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/myeloid-therapeutics (get a free API key).